How Medications Work in Your Body: Absorption, Metabolism & Effects
Understanding pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body) empowers safer, more effective medication use. This knowledge helps you partner with your prescriber and pharmacist.
Pharmacokinetics (ADME)
1. Absorption
Drug entry into systemic circulation.
- Routes: Oral (GI tract), IV (direct), SC/IM, transdermal, inhalational, sublingual/buccal, rectal
- Oral factors: Solubility, permeability, first-pass metabolism, food effects (↑/↓ absorption), gastric pH, motility, efflux transporters (P-gp)
- Bioavailability (F): Fraction reaching circulation unchanged. IV = 100%. Oral often <100%.
2. Distribution
Transport from blood to tissues.
- Volume of distribution (Vd): Theoretical volume drug appears to occupy. High Vd = extensive tissue binding.
- Protein binding: Albumin, α1-acid glycoprotein. Only free (unbound) drug is pharmacologically active.
- Blood-brain barrier: Restricts CNS entry; relevant for neurologic/psychiatric drugs
- Placental transfer: Critical in pregnancy
3. Metabolism (Biotransformation)
Chemical modification, primarily in liver, to increase polarity for excretion.
- Phase I: Oxidation, reduction, hydrolysis (CYPs: 3A4, 2D6, 2C9, 2C19, 1A2). Creates active/inactive/toxic metabolites.
- Phase II: Conjugation (glucuronidation, sulfation, methylation). Usually inactive, renally excreted.
- Genetic polymorphism: CYP2D6, 2C19, TPMT, UGT1A1 → poor/ultrarapid metabolizers
- Drug interactions: Induction (↑ metabolism, ↓ levels) vs. inhibition (↓ metabolism, ↑ toxicity)
4. Excretion
Elimination from body.
- Renal: Glomerular filtration, tubular secretion, reabsorption. Dose adjust in CKD.
- Biliary/fecal: For high MW, protein-bound drugs; enterohepatic recirculation possible
- Pulmonary: Volatile anesthetics, alcohol
- Clearance (CL): Volume of blood cleared per unit time. Half-life (t½) = 0.693 × Vd / CL
Pharmacodynamics
Drug effect at site of action.
- Receptor binding: Agonist (activates), antagonist (blocks), partial agonist, inverse agonist
- Enzyme inhibition/activation
- Ion channel modulation
- Transporter effects
- Dose-response: EC50, Emax, therapeutic window
- Tolerance, tachyphylaxis, sensitization
Key Concepts for Patients
- Steady state: ~5 half-lives with regular dosing
- Loading dose: Rapidly achieve target concentration
- Therapeutic drug monitoring (TDM): For narrow therapeutic index drugs (warfarin, lithium, vancomycin, some biologics)
- Adherence: Missed doses → subtherapeutic levels; doubling up → toxicity
- Food/drug/supplement interactions: Always disclose all substances
Side Effects and Safety
- On-target: Exaggerated therapeutic effect (e.g., hypoglycemia on insulin)
- Off-target: Unrelated receptor effects (e.g., antihistamine sedation)
- Idiosyncratic: Unpredictable, often immune-mediated (DRESS, SJS/TEN)
- Reporting: FDA MedWatch, your pharmacist, prescriber
Your pharmacist is the medication expert on your team. Consult them for interaction checks, administration guidance, and cost-saving alternatives.
Prescription Medications - Related Articles
- Managing Coreg Dosage for Cardiomyopathy: A Doctor-Guided Approach
- The Seven Rights of Medication Administration: Preventing Errors
- Find Generic Drug Names: A Comprehensive Guide
- Orphan Drugs: Definition, Development & the Orphan Drug Act
- Lortab 7.5/500 (UCB 903): What You Need to Know
- Cipramil (Citalopram) Side Effects: What You Need to Know
- Fentanyl: Understanding the Crisis, Risks, and Life-Saving Resources
